Genmab A/S (NASDAQ:GMAB) is one of the most profitable biotech stocks to invest in now. In a report released on July 14, ...

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the most profitable biotech stocks to invest in now. TD Cowen analyst Tyler Van ...

Bio-Techne Corporation (NASDAQ:TECH) is one of the most profitable biotech stocks to invest in now. On July 9, TD Cowen ...

United Therapeutics Corporation (NASDAQ:UTHR) is one of the Best Extremely Profitable Stocks to Buy Right Now. On July 15, ...

TD Cowen has raised its price target for Strategy’s stock from $590 to $680 per share, citing the company’s deepening role as ...

CSX experienced a tough second quarter and first half of 2025, compared to the prior-year’s periods, but saw some sequential ...

In a report released today, William Katz from TD Cowen reiterated a Buy rating on Invesco, with a price target of $29.00. The company’s shares opened today at $21.55. Take advantage of TipRanks ...

Klaviyo, Inc. (NYSE:KVYO) is one of the Most Promising New Technology Stocks According to Wall Street Analysts. On June 23, ...

In addition to TD Cowen, Centene also received a Hold from Robert W. Baird’s Michael Ha in a report issued yesterday. However, on the same day, TR | OpenAI – 4o reiterated a Buy rating on Centene ...

TORONTO and NEW YORK, March 1, 2023/ PRNewswire/- TD Bank Group and Cowen Inc. today announce that TD has completed the acquisition of Cowen. Together, with greater scale, broader capabilities and ...

TD Bank / Anthony Quintano 1. Toronto-Dominion Bank's $1.3 billion move for Cowen underscores that the Canadian lender wants more of the US investment-banking pie.The deal comes after TD agreed to ...